Cell Cycle Inhibitors in Cancer Therapy Current Strategies / edited by Antonio Giordano, Kenneth J. Soprano.

The molecular approach to disease continues to yield a tremendous amount of new information about those aspects of cellular replication that we use to understand, prevent, diagnose, and cure cancer. In Cell Cycle Inhibitors in Cancer Therapy: Current Strategies, recognized clinicians and investigato...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Giordano, Antonio (Editor), Soprano, Kenneth J. (Editor)
Format: eBook
Language:English
Published: Totowa, NJ : Humana Press : Imprint: Humana, 2003.
Edition:1st ed. 2003.
Series:Cancer Drug Discovery and Development,
Springer eBook Collection.
Subjects:
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.

MARC

LEADER 00000nam a22000005i 4500
001 b3204482
003 MWH
005 20191027032101.0
007 cr nn 008mamaa
008 121227s2003 xxu| s |||| 0|eng d
020 |a 9781592594016 
024 7 |a 10.1007/978-1-59259-401-6  |2 doi 
035 |a (DE-He213)978-1-59259-401-6 
050 4 |a E-Book 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
245 1 0 |a Cell Cycle Inhibitors in Cancer Therapy  |h [electronic resource] :  |b Current Strategies /  |c edited by Antonio Giordano, Kenneth J. Soprano. 
250 |a 1st ed. 2003. 
264 1 |a Totowa, NJ :  |b Humana Press :  |b Imprint: Humana,  |c 2003. 
300 |a X, 326 p. 22 illus.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Cancer Drug Discovery and Development,  |x 2196-9906 
490 1 |a Springer eBook Collection 
505 0 |a 1 Cdk Inhibitors: Background and Introduction -- 2 p27, A Prognostic Indicator Reflecting?... -- 3 Cell Cycle Control of Transcription at the G1/S Phase Transition -- 4 Tumor-Suppressor Genes as Diagnostic Tools -- 5 Regulation of Cell Cycle and Apoptosis -- 6 CDK Inhibitors as Targets of Chemoprevention Agents -- 7 Cell Cycle Regulatory Genes as Targets of Retinoids -- 8 Modulators of Cyclin-Dependent Kinases: A Novel Therapeutic Approach for the Treatment of Neoplastic Diseases -- 9 Cell Cycle Regulators: Interactions and Their Role in Diagnosis, Prognosis, and Treatment of Cancer -- 10 Cell Cycle Regulators as Targets of Anticancer Therapy -- 11 Mammalian CDK Inhibitors as Targets of Ubiquitinization in Cancer -- 12 Synthetic Oligopeptides as Cancer Cell Cycle Modulators. 
520 |a The molecular approach to disease continues to yield a tremendous amount of new information about those aspects of cellular replication that we use to understand, prevent, diagnose, and cure cancer. In Cell Cycle Inhibitors in Cancer Therapy: Current Strategies, recognized clinicians and investigators review in a comprehensible and user-friendly style all the latest information about the molecular biology of cell-cycle control and demonstrate its clinical relevance to understanding neoplastic diseases. Topics range from Cdk inhibitors and cell cycle regulators to the prognostic value of p27 and tumor-suppressor genes as diagnostic tools. Actual case studies show how the new molecular understanding has produced such drugs as Flavopiridol and Sulindac. Up-to-date and richly instructive, Cell Cycle Inhibitors in Cancer Therapy: Current Strategies brings all the recent critical research findings to bear on clinical practice, and clearly shows their powerful impact on the diagnostics, prognostics, and therapeutics of cancer, AIDS, and cardiovascular disease. 
590 |a Loaded electronically. 
590 |a Electronic access restricted to members of the Holy Cross Community. 
650 0 |a Oncology  . 
650 0 |a Cancer research. 
690 |a Electronic resources (E-books) 
700 1 |a Giordano, Antonio.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Soprano, Kenneth J.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
830 0 |a Cancer Drug Discovery and Development,  |x 2196-9906 
830 0 |a Springer eBook Collection. 
856 4 0 |u https://holycross.idm.oclc.org/login?auth=cas&url=https://doi.org/10.1007/978-1-59259-401-6  |3 Click to view e-book  |t 0 
907 |a .b32044823  |b 04-18-22  |c 02-26-20 
998 |a he  |b 02-26-20  |c m  |d @   |e -  |f eng  |g xxu  |h 0  |i 1 
912 |a ZDB-2-SME 
912 |a ZDB-2-BAE 
950 |a Medicine (Springer-11650) 
902 |a springer purchased ebooks 
903 |a SEB-COLL 
945 |f  - -   |g 1  |h 0  |j  - -   |k  - -   |l he   |o -  |p $0.00  |q -  |r -  |s b   |t 38  |u 0  |v 0  |w 0  |x 0  |y .i21176462  |z 02-26-20 
999 f f |i 3306b919-591f-53ca-9055-fd88c0314ae8  |s 6904539e-2eff-53af-b17b-250ba56f810d  |t 0 
952 f f |p Online  |a College of the Holy Cross  |b Main Campus  |c E-Resources  |d Online  |t 0  |e E-Book  |h Library of Congress classification  |i Elec File